Curasight: Interim report Q1 2023
Astellas Announces Commitments to 3rd Phase of GHIT Fund Replenishment
Government of Japan Expresses its Pledge of US$200 Million to GHIT Fund/UNDP Replenishment
Sector to Reach $10.1 Billion at a 15.4% CAGR
Les leaders du secteur biopharmaceutique se réunissent au Veeva R&D and Quality Summit pour faire progresser l’innovation pour l’industrie et les patients USA – Français USA – English USA – Deutsch USA – español
America’s Best Wings: Everything You Need to Know
Toulouse: a congress of forensic medicine to discuss the virtual autopsy which reveals the secrets of death
My town in 10 years: the mayor of Eauze wants to “make the town attractive”
Limoux. Gendarmerie cadets at the Chénier nursing home
What tools should be put in place in the face of a persistent and unavoidable drought?
Medical tension in Pibrac too
COPENHAGEN, Denmark, May 25, 2023 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – TICKER: CURAS) hereby publishes the interim report Q1 2023. The interim report is...
